Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)
Autor(a) principal: | |
---|---|
Data de Publicação: | 2013 |
Outros Autores: | , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.1186/1475-2891-12-37 http://repositorio.unifesp.br/handle/11600/36192 |
Resumo: | Background: Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease, which includes a spectrum of hepatic pathology such as simple steatosis, steatohepatitis, fibrosis and cirrhosis. the increased serum levels of homocysteine (Hcy) may be associated with hepatic fat accumulation. Genetic mutations in the folate route may only mildly impair Hcy metabolism. the aim of this study was to investigate the relation between liver steatosis with plasma homocysteine level and MTHFR C677T and A1298C polymorphisms in Brazilian patients with NAFLD.Methods: Thirty-five patients diagnosed with NAFLD by liver biopsy and forty-five healthy controls neither age nor sex matched were genotyped for C677T and A1298C MTHFR polymorphisms using PCR-RFLP and PCR-ASA, respectively, and Hcy was determined by HPLC. All patients were negative for markers of Wilson's, hemochromatosis and autoimmune diseases. Their daily alcohol intake was less than 100 g/week. A set of metabolic and serum lipid markers were also measured at the time of liver biopsies.Results: the plasma Hcy level was higher in NAFLD patients compared to the control group (p = 0.0341). No statistical difference for genotypes 677C/T (p = 0.110) and 1298A/C (p = 0.343) in patients with NAFLD and control subjects was observed. the genotypes distribution was in Hardy-Weinberg equilibrium (677C/T p = 0.694 and 1298 A/C p = 0.188). the group of patients and controls showed a statistically significant difference (p < 0.001) for BMI and HOMA_IR, similarly to HDL cholesterol levels (p < 0,006), AST, ALT, gamma GT, AP and triglycerides levels (p < 0.001). A negative correlation was observed between levels of vitamin B12 and Hcy concentration (p = 0.005).Conclusion: Our results indicate that plasma Hcy was higher in NAFLD than controls. the MTHFR C677T and A1298C polymorphisms did not differ significantly between groups, despite the 677TT homozygous frequency was higher in patients (17.14%) than in controls (677TT = 4.44%) (p > 0.05). the suggested genetic susceptibility to the MTHFR C677T and A1298C should be confirmed in large population based studies. |
id |
UFSP_b9fc04dded344e33f226936543291beb |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/36192 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)Fatty liverNon-alcoholic steatohepatitisMethylenetetrahydrofolate reductase (MTHFR)Oxidative stressPolymorphismsBackground: Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease, which includes a spectrum of hepatic pathology such as simple steatosis, steatohepatitis, fibrosis and cirrhosis. the increased serum levels of homocysteine (Hcy) may be associated with hepatic fat accumulation. Genetic mutations in the folate route may only mildly impair Hcy metabolism. the aim of this study was to investigate the relation between liver steatosis with plasma homocysteine level and MTHFR C677T and A1298C polymorphisms in Brazilian patients with NAFLD.Methods: Thirty-five patients diagnosed with NAFLD by liver biopsy and forty-five healthy controls neither age nor sex matched were genotyped for C677T and A1298C MTHFR polymorphisms using PCR-RFLP and PCR-ASA, respectively, and Hcy was determined by HPLC. All patients were negative for markers of Wilson's, hemochromatosis and autoimmune diseases. Their daily alcohol intake was less than 100 g/week. A set of metabolic and serum lipid markers were also measured at the time of liver biopsies.Results: the plasma Hcy level was higher in NAFLD patients compared to the control group (p = 0.0341). No statistical difference for genotypes 677C/T (p = 0.110) and 1298A/C (p = 0.343) in patients with NAFLD and control subjects was observed. the genotypes distribution was in Hardy-Weinberg equilibrium (677C/T p = 0.694 and 1298 A/C p = 0.188). the group of patients and controls showed a statistically significant difference (p < 0.001) for BMI and HOMA_IR, similarly to HDL cholesterol levels (p < 0,006), AST, ALT, gamma GT, AP and triglycerides levels (p < 0.001). A negative correlation was observed between levels of vitamin B12 and Hcy concentration (p = 0.005).Conclusion: Our results indicate that plasma Hcy was higher in NAFLD than controls. the MTHFR C677T and A1298C polymorphisms did not differ significantly between groups, despite the 677TT homozygous frequency was higher in patients (17.14%) than in controls (677TT = 4.44%) (p > 0.05). the suggested genetic susceptibility to the MTHFR C677T and A1298C should be confirmed in large population based studies.Univ Pernambuco, Sch Med, Recife, PE, BrazilUniv Pernambuco, Pediat Hematol & Oncol Ctr, Recife, PE, BrazilLiver Inst Pernambuco, Recife, PE, BrazilUniv Pernambuco, Inst Biol Sci, Recife, PE, BrazilUniversidade Federal de São Paulo, Dept Pediat, São Paulo, BrazilUniv São Paulo, Sch Med, São Paulo, BrazilInst Figado Pernambuco, BR-50100130 Santo Amaro Recife, BrazilUniversidade Federal de São Paulo, Dept Pediat, São Paulo, BrazilWeb of ScienceBiomed Central LtdUniv PernambucoLiver Inst PernambucoUniversidade Federal de São Paulo (UNIFESP)Universidade de São Paulo (USP)Inst Figado PernambucoCarvalho, Sylene Coutinho Rampche deMuniz, Maria Tereza CartaxoSiqueira, Maria Deozete VieiraSiqueira, Erika Rabelo ForteGomes, Adriana VieiraSilva, Karina AlvesBezerra, Lais Carvalho LumaD'Almeida, Vania [UNIFESP]Oliveira, Claudia Pinto Marques Souza dePereira, Leila Maria M. Beltrao2016-01-24T14:31:33Z2016-01-24T14:31:33Z2013-04-02info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion5application/pdfhttp://dx.doi.org/10.1186/1475-2891-12-37Nutrition Journal. London: Biomed Central Ltd, v. 12, 5 p., 2013.10.1186/1475-2891-12-37WOS000317666000001.pdf1475-2891http://repositorio.unifesp.br/handle/11600/36192WOS:000317666000001engNutrition Journalinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-06T15:54:15Zoai:repositorio.unifesp.br/:11600/36192Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-06T15:54:15Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD) |
title |
Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD) |
spellingShingle |
Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD) Carvalho, Sylene Coutinho Rampche de Fatty liver Non-alcoholic steatohepatitis Methylenetetrahydrofolate reductase (MTHFR) Oxidative stress Polymorphisms |
title_short |
Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD) |
title_full |
Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD) |
title_fullStr |
Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD) |
title_full_unstemmed |
Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD) |
title_sort |
Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD) |
author |
Carvalho, Sylene Coutinho Rampche de |
author_facet |
Carvalho, Sylene Coutinho Rampche de Muniz, Maria Tereza Cartaxo Siqueira, Maria Deozete Vieira Siqueira, Erika Rabelo Forte Gomes, Adriana Vieira Silva, Karina Alves Bezerra, Lais Carvalho Luma D'Almeida, Vania [UNIFESP] Oliveira, Claudia Pinto Marques Souza de Pereira, Leila Maria M. Beltrao |
author_role |
author |
author2 |
Muniz, Maria Tereza Cartaxo Siqueira, Maria Deozete Vieira Siqueira, Erika Rabelo Forte Gomes, Adriana Vieira Silva, Karina Alves Bezerra, Lais Carvalho Luma D'Almeida, Vania [UNIFESP] Oliveira, Claudia Pinto Marques Souza de Pereira, Leila Maria M. Beltrao |
author2_role |
author author author author author author author author author |
dc.contributor.none.fl_str_mv |
Univ Pernambuco Liver Inst Pernambuco Universidade Federal de São Paulo (UNIFESP) Universidade de São Paulo (USP) Inst Figado Pernambuco |
dc.contributor.author.fl_str_mv |
Carvalho, Sylene Coutinho Rampche de Muniz, Maria Tereza Cartaxo Siqueira, Maria Deozete Vieira Siqueira, Erika Rabelo Forte Gomes, Adriana Vieira Silva, Karina Alves Bezerra, Lais Carvalho Luma D'Almeida, Vania [UNIFESP] Oliveira, Claudia Pinto Marques Souza de Pereira, Leila Maria M. Beltrao |
dc.subject.por.fl_str_mv |
Fatty liver Non-alcoholic steatohepatitis Methylenetetrahydrofolate reductase (MTHFR) Oxidative stress Polymorphisms |
topic |
Fatty liver Non-alcoholic steatohepatitis Methylenetetrahydrofolate reductase (MTHFR) Oxidative stress Polymorphisms |
description |
Background: Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease, which includes a spectrum of hepatic pathology such as simple steatosis, steatohepatitis, fibrosis and cirrhosis. the increased serum levels of homocysteine (Hcy) may be associated with hepatic fat accumulation. Genetic mutations in the folate route may only mildly impair Hcy metabolism. the aim of this study was to investigate the relation between liver steatosis with plasma homocysteine level and MTHFR C677T and A1298C polymorphisms in Brazilian patients with NAFLD.Methods: Thirty-five patients diagnosed with NAFLD by liver biopsy and forty-five healthy controls neither age nor sex matched were genotyped for C677T and A1298C MTHFR polymorphisms using PCR-RFLP and PCR-ASA, respectively, and Hcy was determined by HPLC. All patients were negative for markers of Wilson's, hemochromatosis and autoimmune diseases. Their daily alcohol intake was less than 100 g/week. A set of metabolic and serum lipid markers were also measured at the time of liver biopsies.Results: the plasma Hcy level was higher in NAFLD patients compared to the control group (p = 0.0341). No statistical difference for genotypes 677C/T (p = 0.110) and 1298A/C (p = 0.343) in patients with NAFLD and control subjects was observed. the genotypes distribution was in Hardy-Weinberg equilibrium (677C/T p = 0.694 and 1298 A/C p = 0.188). the group of patients and controls showed a statistically significant difference (p < 0.001) for BMI and HOMA_IR, similarly to HDL cholesterol levels (p < 0,006), AST, ALT, gamma GT, AP and triglycerides levels (p < 0.001). A negative correlation was observed between levels of vitamin B12 and Hcy concentration (p = 0.005).Conclusion: Our results indicate that plasma Hcy was higher in NAFLD than controls. the MTHFR C677T and A1298C polymorphisms did not differ significantly between groups, despite the 677TT homozygous frequency was higher in patients (17.14%) than in controls (677TT = 4.44%) (p > 0.05). the suggested genetic susceptibility to the MTHFR C677T and A1298C should be confirmed in large population based studies. |
publishDate |
2013 |
dc.date.none.fl_str_mv |
2013-04-02 2016-01-24T14:31:33Z 2016-01-24T14:31:33Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1186/1475-2891-12-37 Nutrition Journal. London: Biomed Central Ltd, v. 12, 5 p., 2013. 10.1186/1475-2891-12-37 WOS000317666000001.pdf 1475-2891 http://repositorio.unifesp.br/handle/11600/36192 WOS:000317666000001 |
url |
http://dx.doi.org/10.1186/1475-2891-12-37 http://repositorio.unifesp.br/handle/11600/36192 |
identifier_str_mv |
Nutrition Journal. London: Biomed Central Ltd, v. 12, 5 p., 2013. 10.1186/1475-2891-12-37 WOS000317666000001.pdf 1475-2891 WOS:000317666000001 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Nutrition Journal |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
5 application/pdf |
dc.publisher.none.fl_str_mv |
Biomed Central Ltd |
publisher.none.fl_str_mv |
Biomed Central Ltd |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268329341222912 |